$SGYP.. Completes Enrollment for the Second Pivotal Ph.3 Trial of Plecanatide. http://t.co/G021bTGVUu Topline data will be in Q3. Key catalyst to watch for!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.